Omnicell Inc (OMCL) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally.

Total Cash From Operating Activities Chart for Omnicell Inc

Omnicell Inc (OMCL) operating cash flow for FY2025 was USD 127.3M, a -32.2% change from FY2024. Omnicell Inc's operating cash flow moved from USD -19.1M in 2000 to USD 127.3M in 2025 over 25 years. Operating cash flow compound annual growth rate: 5-year CAGR of -7.3%, 10-year CAGR of 14.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$1.72B
Implied Share Price
$37.75
Enterprise Value
$1.41B
Revenue (TTM)
$1.25B
EBITDA
$82.18M
Profit Margin
3.14%
Trailing P/E
44.94
Forward P/E
29.50
Price/Book (MRQ)
1.17
Price/Sales (TTM)
1.38
EV/EBITDA
9.87
EV/Revenue
1.13
Dividend Yield
—
Book Value
$28.32
Free Cash Flow (FY2025)
$86.89M
Free Cash Flow Yield
5.06%

Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.